MEGAN FULKERSON: Open Payments
NPI 1932462348 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 51 payments from 18 companies in 2025. Trend: 2023 $1,356 · 2024 $1,129 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $280 |
| PFIZER INC. | 9 | $163 |
| 180 Medical, Inc. | 5 | $121 |
| Sumitomo Pharma America, Inc. | 4 | $104 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $90 |
| ABBVIE INC. | 3 | $64 |
| Astellas Pharma US Inc | 3 | $62 |
| UROGEN PHARMA, INC. | 2 | $58 |
| Olympus America Inc. | 2 | $45 |
| Boston Scientific Corporation | 1 | $45 |
Products named: XTANDI, RYBREVANT, ERLEADA, GEMTESA, Bard Urinary Drainage Bag, BOTOX, AMS 700, PLUVICTO.
Industry payments across KY — which companies pay providers there.
